Fintech▲ 80

BullFrog AI Signs Commercial Agreement with Pharma

Globenewswire·March 30, 2026 at 11:30 AM

BullFrog AI has announced a significant commercial agreement with a top-tier global pharmaceutical company. This collaboration will utilize BullFrog AI's proprietary technology to identify and prioritize therapeutic targets for major depressive disorder. The agreement serves as a strong validation of the company's AI capabilities in drug discovery and development, potentially accelerating the path to new treatments.

BullFrog AI Signs Commercial Agreement with Pharma

NY Fed: Mobile Sports Betting Increases Credit Delinquency

Labor Department Eases 401(k) Alternative Investment Access

US rule may open trillions in 401(k) to crypto

Businesses Adapt AI Budgeting to Usage-Based Pricing